2025.12.15
TCROSS Co., Ltd. is pleased to announce that our CEO, Satoru Hashimoto, will present at HIMSS 2026, the world’s largest global health information and technology event, to be held from March 9–12, 2026 in Las Vegas, USA.
InsighTCROSS , which is independently developed by TCROSS Co., Ltd. to support strategic decision-making and improve efficiency in pharmaceutical and medical device sales and marketing by enabling:
In this session, Hashimoto will unveil EarlyScripters, a newly developed algorithm designed to identify the “first adopters” — the physicians most likely to prescribe a new product at launch.
The New Standard in Pharma Marketing Efficiency: AI That Identifies Early Adopters and Eliminates Ineffective Spend
Global spending on pharmaceutical sales and marketing has reached tens of billions of dollars annually, yet up to 30% of marketing content is wasted due to failure in reaching the right target customers. This inefficiency not only reduces return on investment but also delays access to innovative therapies for patients.
InsighTCROSS is an AI-driven decision-support software developed to eliminate such waste and maximize sales revenue. By integrating physician-level behavioral data with real-world sales outcomes, InsighTCROSS enables pharmaceutical and MedTech companies to identify the most effective activities and optimal customer segments with high precision.
In this session, we will introduce the platform’s new capability to predict and identify physicians with a high likelihood of adopting newly launched products—a task traditionally considered extremely difficult. Real-world use case will be presented to demonstrate how AI-driven optimization transforms marketing and sales strategies, leading to measurable improvements in productivity, ROI, and speed-to-market.